At the World Conference on Lung Health Nov. 2, the Dutch Ministry of Foreign Affairs announced a $38.3 million investment in three partnerships working to develop drugs and vaccines to fight tuberculosis.
The commitment is the largest investment a single country has made in research of the illness to date.
Aeras Global TB Vaccine Foundation will receive $23.5 million for preclinical work and clinical trials of vaccine candidates.
The Global Alliance for TB Drug Development will get $10.2 million to expand drug discovery projects, develop tools for clinical work and increase efforts globally for the introduction of new drug regimens.
The Foundation for Innovative New Diagnostics will receive $5.1 million for the development of diagnostic tests.
Billed as the second-deadliest infectious disease behind AIDS, tuberculosis kills nearly 2 million people each year.